AI could shorten pharmaceutical trials, boost patient matching, Intel report says

The company says algorithms can simplify trials and accelerate time to market for new drugs.

from healthcareitnews

If You Enjoyed This, Take 5 Seconds To Share It

• 
• 
• 
• 
• 
•